Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems
| dc.contributor.author | Rudilla Mateo, Héctor | |
| dc.contributor.author | Fusté i Domínguez, Ester | |
| dc.contributor.author | Cajal Visa, Yolanda | |
| dc.contributor.author | Rabanal Anglada, Francesc | |
| dc.contributor.author | Vinuesa Aumedes, Teresa | |
| dc.contributor.author | Viñas, Miquel | |
| dc.date.accessioned | 2016-11-02T09:16:37Z | |
| dc.date.available | 2016-11-02T09:16:37Z | |
| dc.date.issued | 2016-09-12 | |
| dc.date.updated | 2016-11-02T09:16:42Z | |
| dc.description.abstract | The aim was to explore the antimicrobial activity of a synthetic peptide (AMP38) and its synergy with imipenem against imipenem-resistant Pseudomonas aeruginosa. The main mechanism of imipenem resistance is the loss or alteration of protein OprD. Time-kill and minimal biofilm eradication concentration (MBEC) determinations were carried out by using clinical imipenem-resistant strains. AMP38 was markedly synergistic with imipenem when determined in imipenem-resistant P. aeruginosa. MBEC obtained for the combination of AMP38 and imipenem was of 62.5 μg/mL, whereas the MBEC of each antimicrobial separately was 500 μg/mL. AMP38 should be regarded as a promising antimicrobial to fight MDR P. aeruginosa infections. Moreover, killing effect and antibiofilm activity of AMP38 plus imipenem was much higher than that of colistin plus imipenem. | |
| dc.format.extent | 12 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 663969 | |
| dc.identifier.issn | 1420-3049 | |
| dc.identifier.pmid | 27626405 | |
| dc.identifier.uri | https://hdl.handle.net/2445/103103 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.3390/molecules21091223 | |
| dc.relation.ispartof | Molecules, 2016, vol. 21, num. 9, p. 1223 | |
| dc.relation.uri | https://doi.org/10.3390/molecules21091223 | |
| dc.rights | cc-by (c) Rudilla, Héctor et al., 2016 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es | |
| dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | |
| dc.subject.classification | Pseudomonas | |
| dc.subject.classification | Síntesi de pèptids | |
| dc.subject.classification | Pèptids | |
| dc.subject.classification | Biofilms | |
| dc.subject.classification | Antibiòtics | |
| dc.subject.other | Pseudomonas | |
| dc.subject.other | Peptide synthesis | |
| dc.subject.other | Peptides | |
| dc.subject.other | Biofilms | |
| dc.subject.other | Antibiotics | |
| dc.title | Synergistic antipseudomonal effects of synthetic peptide AMP38 and carbapenems | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1
Col·leccions
Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))
Articles publicats en revistes (Química Inorgànica i Orgànica)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)
Articles publicats en revistes (Infermeria de Salut Pública, Salut mental i Maternoinfantil)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Institut de Nanociència i Nanotecnologia (IN2UB))
Articles publicats en revistes (Química Inorgànica i Orgànica)